176 related articles for article (PubMed ID: 17530505)
1. Insulin resistance and inflammation - A further systemic complication of COPD.
Bolton CE; Evans M; Ionescu AA; Edwards SM; Morris RH; Dunseath G; Luzio SD; Owens DR; Shale DJ
COPD; 2007 Jun; 4(2):121-6. PubMed ID: 17530505
[TBL] [Abstract][Full Text] [Related]
2. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
3. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
4. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
5. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
[TBL] [Abstract][Full Text] [Related]
6. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.
López-Bermejo A; Hernández-Aguado I; Vera IJ; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953
[TBL] [Abstract][Full Text] [Related]
7. Changes in body mass index are associated with changes in inflammatory and endothelial dysfunction biomarkers in obese prepubertal children after 9 months of body mass index SD score loss.
Martos R; Valle M; Morales RM; Cañete R; Gascón F; Urbano MM
Metabolism; 2009 Aug; 58(8):1153-60. PubMed ID: 19477472
[TBL] [Abstract][Full Text] [Related]
8. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus.
Kadoglou NP; Iliadis F; Angelopoulou N; Perrea D; Ampatzidis G; Liapis CD; Alevizos M
Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):837-43. PubMed ID: 18043308
[TBL] [Abstract][Full Text] [Related]
10. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Neubauer K; Kustrzeba-Wojcicka I; Terlecki G; Gamian A
Exp Oncol; 2008 Mar; 30(1):75-80. PubMed ID: 18438346
[TBL] [Abstract][Full Text] [Related]
11. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
12. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
13. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
Breyer MK; Spruit MA; Celis AP; Rutten EP; Janssen PP; Wouters EF;
Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
[TBL] [Abstract][Full Text] [Related]
14. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines in insulin-treated patients with type 2 diabetes.
Mavridis G; Souliou E; Diza E; Symeonidis G; Pastore F; Vassiliou AM; Karamitsos D
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):471-6. PubMed ID: 17976964
[TBL] [Abstract][Full Text] [Related]
16. Systemic and airway inflammation and the presence of emphysema in patients with COPD.
Papaioannou AI; Mazioti A; Kiropoulos T; Tsilioni I; Koutsokera A; Tanou K; Nikoulis DJ; Georgoulias P; Zakynthinos E; Gourgoulianis KI; Kostikas K
Respir Med; 2010 Feb; 104(2):275-82. PubMed ID: 19854037
[TBL] [Abstract][Full Text] [Related]
17. Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects.
Heliövaara MK; Teppo AM; Karonen SL; Tuominen JA; Ebeling P
Diabetes Obes Metab; 2005 Nov; 7(6):729-36. PubMed ID: 16219017
[TBL] [Abstract][Full Text] [Related]
18. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
19. Circulating ghrelin in patients with chronic obstructive pulmonary disease.
Luo FM; Liu XJ; Li SQ; Wang ZL; Liu CT; Yuan YM
Nutrition; 2005; 21(7-8):793-8. PubMed ID: 15975486
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
